A new blood test designed to detect early signs of pancreatic cancer is being trialled in the UK. The genomic test analyses ...

Experts hope the test will enable doctors to pick up early signs of the deadly disease, which can have vague or no symptoms.

The test is being trialled in patients with a recent diagnosis of type 2 diabetes – a known risk factor for pancreatic cancer ...

Scientists have hailed a “milestone” in leukaemia care for patients after a UK trial found a chemotherapy-free approach to ...

A surprising new study has found that some common medication used to make people feel better might also be effective in the ...

This single-arm, multicenter Phase II study assessed the efficacy and safety of olverembatinib in combination with the VP ...